THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 152 filers reported holding THERAVANCE INC in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $1,541,000 | +46.8% | 146,187 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,050,000 | -80.8% | 146,187 | -51.6% | 0.00% | -80.0% |
Q2 2015 | $5,462,000 | +3.1% | 302,245 | -10.3% | 0.01% | +25.0% |
Q1 2015 | $5,300,000 | +45.7% | 337,125 | +31.1% | 0.00% | +33.3% |
Q4 2014 | $3,638,000 | -91.9% | 257,083 | -90.2% | 0.00% | -92.1% |
Q3 2014 | $44,910,000 | -47.9% | 2,627,862 | -9.3% | 0.04% | -47.9% |
Q2 2014 | $86,240,000 | +17.2% | 2,895,897 | +21.7% | 0.07% | +14.1% |
Q1 2014 | $73,599,000 | +1290.0% | 2,378,752 | +1501.5% | 0.06% | +1180.0% |
Q4 2013 | $5,295,000 | -1.3% | 148,534 | +13.2% | 0.01% | 0.0% |
Q3 2013 | $5,366,000 | +2.3% | 131,219 | -3.6% | 0.01% | -16.7% |
Q2 2013 | $5,245,000 | – | 136,123 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |